Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLO | LBRX | REPL | ||
| Company | Allogene Therapeutics Inc | Lb Pharmaceuticals Inc | Replimune Group Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.14 | 23.53 | 7.05 | ||
| High | 2.60 | 24.47 | 7.35 | ||
| Low | 2.13 | 23.47 | 6.76 | ||
| Latest | 2.44 | 23.67 | 6.98 | ||
| Change | +0.37 | +0.14 | unch | ||
| % Change | +17.87% | +0.59% | unch | ||
| Volume | 11,688,800 | 129,300 | 1,614,200 | ||
| 20-Day Average Volume | 6,119,615 | 289,390 | 1,492,690 | ||
| Previous Close | 2.07 | 23.53 | 6.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.45 | 24.35 | 7.50 | ||
| 20-Day Raw Stochastic | 51.68% | 27.48% | 18.46% | ||
| 20-Day Relative Strength | 55.90 | 50.34 | 43.67 | ||
| Weighted Alpha | +88.61 | +48.44 | +3.50 | ||
| Today's Opinion | 80% Buy | N/A | 64% Sell | ||
| Previous Opinion | 80% Buy | N/A | 64% Sell | ||
| Last Month's Opinion | 100% Buy | N/A | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/16/26 | -10.54% since 03/16/26 | -5.16% since 03/16/26 | ||
| Low | 2.06 on 03/20/26 | 23.05 on 03/19/26 | 6.50 on 03/19/26 | ||
| High | 2.60 on 03/23/26 | 26.51 on 03/17/26 | 7.57 on 03/17/26 | ||
| 1-Month | |||||
| %Chg | +17.31% since 02/23/26 | -1.42% since 02/23/26 | -16.81% since 02/23/26 | ||
| Low | 2.06 on 03/20/26 | 22.20 on 03/02/26 | 6.50 on 03/19/26 | ||
| High | 2.80 on 02/27/26 | 27.55 on 03/16/26 | 9.10 on 03/09/26 | ||
| 3-Month | |||||
| %Chg | +79.41% since 12/23/25 | +6.86% since 12/23/25 | -28.19% since 12/23/25 | ||
| Low | 1.29 on 12/30/25 | 18.43 on 01/12/26 | 6.50 on 03/19/26 | ||
| High | 2.80 on 02/27/26 | 27.55 on 03/16/26 | 10.27 on 12/24/25 | ||
| 6-Month | |||||
| %Chg | +108.55% since 09/23/25 | +58.86% since 09/23/25 | +61.20% since 09/23/25 | ||
| Low | 1.04 on 11/07/25 | 13.36 on 09/26/25 | 3.90 on 09/24/25 | ||
| High | 2.80 on 02/27/26 | 27.55 on 03/16/26 | 11.26 on 12/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 594,818 | 598,827 | 576,360 | ||
| Shares Outstanding, K | 243,778 | 25,299 | 82,573 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -190,890,000 | -63,102,000 | -247,300,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -38,810,000 | -3,560,000 | -70,930,000 | ||
| 60-Month Beta | 0.50 | N/A | 0.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 03/12/26 | -0.61 on 11/06/25 | -0.77 on 02/03/26 | ||
| Latest Earnings Date | 05/12/26 | 03/26/26 | 05/28/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||